0001694399-19-000002.txt : 20190731 0001694399-19-000002.hdr.sgml : 20190731 20190731133854 ACCESSION NUMBER: 0001694399-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190731 DATE AS OF CHANGE: 20190731 EFFECTIVENESS DATE: 20190731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Salerno Pharmaceuticals, LP CENTRAL INDEX KEY: 0001694399 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-345477 FILM NUMBER: 19988227 BUSINESS ADDRESS: STREET 1: 610 NEWPORT CENTER DRIVE,SUITE 330 CITY: NEWPORT BEACH STATE: CA ZIP: 92660 BUSINESS PHONE: 949-706-3600 MAIL ADDRESS: STREET 1: 610 NEWPORT CENTER DRIVE,SUITE 330 CITY: NEWPORT BEACH STATE: CA ZIP: 92660 FORMER COMPANY: FORMER CONFORMED NAME: TCG Fluent Pharma Investors LP DATE OF NAME CHANGE: 20170111 D 1 primary_doc.xml X0708 D LIVE 0001694399 Salerno Pharmaceuticals, LP 610 NEWPORT CENTER DRIVE SUITE 330 NEWPORT BEACH CA CALIFORNIA 92660 949-706-3600 DELAWARE TCG Fluent Pharma Investors LP Limited Partnership true 2016 Thomas W. Courtney, Jr. 610 Newport Center Drive Suite 330 Newport Beach CA CALIFORNIA 92660 Executive Officer Manager of Issuer's General Partner Edward McKenna 610 Newport Center Drive Suite 330 Newport Beach CA CALIFORNIA 92660 Executive Officer Manager of Issuer's General Partner Pharmaceuticals No Revenues 06b false 2019-07-19 false true false 0 1831692 625437 1206255 false 11 0 0 0 false Salerno Pharmaceuticals, LP /Thomas W. Courtney, Jr./ Thomas W. Courtney, Jr. Manager of General Partner 2019-07-31